Michael Page International stresses on plans to continue its geographic expansion in emerging markets due to many long-term growth opportunities, especially in Latin America and Asia. In spite of expansion plans it remains cautious about the current macro economic outlook.
U.K. house prices dropped at the slowest pace since June 2010 in March, driven by the better economic prospects and buying ahead of the expiry of stamp duty exemption, according to the latest RICS UK Housing Market Survey.
Vedanta Resources has reported a slump in its full-year iron ore output for the year ending March 2012 at 13.8 million tonnes compared to 18.8 million tonnes a year ago, as a ban on mining in the southern Indian state of Karnataka and logistical bottlenecks in Goa continued to bite.
Volex Group says its trading will be in line with current market expectations for the twelve months to April 1, 2012 despite increased global economic uncertainty, which resulted slow growth in Q3 FY 2012.
The April outlook for British Pound Sterling is expected to be resilient, mainly due to recent PMI data releases about services sector, construction and manufacturing of the UK economy and also struggling eurozone economy.
Halfords Group expects its full-year gross margins to decline by 130 to 150 basis points. It says the expected decline is in line with market expectations although it is worse than the forecast at least 100 basis points given in November.The group is scheduled to release its pre-close trading update on Thursday.
Robert Walters says it is well positioned to exploit opportunities through long-term investment and cost management and is committed to expand in markets which offer the best prospects for growth, its future investment plans may reflect this.
BTG Plc has raised its revenue estimate for the year ended 31 March 2012 to £190 - £195 million from the previous guidance of £160 - £165 million due to the robust trading in the Licensing & Biotechnology business, which was significantly ahead of expectations and higher than anticipated royalties from BeneFIX and Zytiga.